DRTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as DRTSW
Alpha Tau Medical Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 9, 2026
$12.62+0.33 (+2.69%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Alpha Tau Medical's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 12 sales
Net sold $1.56M
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. | 14,110,121 | 19.99% | 13D (active) | Apr 24, 2025 |
| Uzi Sofer | 13,702,361 | 15.80% | 13G (passive) | Dec 31, 2022 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Uzi Sofer | Chief Executive Officer, Director | 4,680 | Mar 18, 2026 |
| Raphi Levy | Chief Financial Officer | 93,051 | Aug 25, 2026 |
| Maya Netser | Director | 4,680 | Mar 18, 2026 |
| Michael Avruch | Director | 1,571,961 | Mar 18, 2026 |
| David Mark Milch | Director | 118,110 | Mar 18, 2026 |
| Alan Adler | Director | 54,367 | Mar 18, 2026 |
| Nadav Kidron | Director | 2,986 | Mar 18, 2026 |
| S. Morry Blumenfeld | Director | 4,680 | Mar 18, 2026 |
| Ruth Alon | Director | 4,680 | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Raphi Levy Chief Financial Officer | Aug 21, 2026 | Option exercise | +2,871 | $2.98 | $8.56K | 93,051 |
| Raphi Levy Chief Financial Officer | Aug 21, 2026 | Sale(10b5-1 plan) | −2,871 | $15.00 | $43.07K | 90,180 |
| Raphi Levy Chief Financial Officer | Aug 11, 2026 | Option exercise | +17,730 | $2.98 | $52.84K | 107,910 |
| Raphi Levy Chief Financial Officer | Aug 11, 2026 | Sale(10b5-1 plan) | −17,730 | $14.00 | $248.22K | 90,180 |
| Raphi Levy Chief Financial Officer | Jul 6, 2026 | Option exercise | +2,270 | $2.98 | $6.76K | 92,450 |
| Raphi Levy Chief Financial Officer | Jul 6, 2026 | Sale(10b5-1 plan) | −2,270 | $14.00 | $31.78K | 90,180 |
| Raphi Levy Chief Financial Officer | Jul 2, 2026 | Option exercise | +17,873 | $2.98 | $53.26K | 108,053 |
| Raphi Levy Chief Financial Officer | Jul 2, 2026 | Sale(10b5-1 plan) | −17,873 | $13.00 | $232.35K | 90,180 |
| Raphi Levy Chief Financial Officer | Jul 1, 2026 | Sale(10b5-1 plan) | −2,127 | $13.02 | $27.69K | 90,180 |
| Raphi Levy Chief Financial Officer | Jul 1, 2026 | Option exercise | +2,127 | $2.98 | $6.34K | 92,307 |
| Raphi Levy Chief Financial Officer | Jun 30, 2026 | Sale(10b5-1 plan) | −20,000 | $12.00 | $240.00K | 90,180 |
| Raphi Levy Chief Financial Officer | Jun 25, 2026 | Sale(10b5-1 plan) | −15,778 | $11.00 | $173.56K | 110,180 |
| Raphi Levy Chief Financial Officer | Jun 25, 2026 | Sale(10b5-1 plan) | −4,222 | $11.00 | $46.44K | 125,958 |
| Raphi Levy Chief Financial Officer | Jun 23, 2026 | Sale(10b5-1 plan) | −2,500 | $10.00 | $25.00K | 130,180 |
| Raphi Levy Chief Financial Officer | Jun 23, 2026 | Sale(10b5-1 plan) | −15,000 | $9.47 | $142.05K | 132,680 |
| Raphi Levy Chief Financial Officer | Jun 3, 2026 | Sale | −17,500 | $10.90 | $190.75K | 162,680 |
| Raphi Levy Chief Financial Officer | Jun 3, 2026 | Sale | −15,000 | $10.76 | $161.40K | 147,680 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| (Raphi) Aryeh Levy Raphael Officer | Aug 21, 2026 | 5,000 | $71.80K | Aug 21, 2026 | Shares acquired upon exercise of employee stock options |
| Raphi Levy Officer | Jul 6, 2026 | 20,000 | $264.60K | Jul 6, 2026 | Shares acquired upon exercise of employee stock options |
| Raphi Levy Officer | Jul 2, 2026 | 20,000 | $251.60K | Jul 1, 2026 | Shares acquired upon exercise of employee stock options |
| Raphi Levy Officer | Jun 30, 2026 | 20,000 | $224.40K | Jun 30, 2026 | Shares issued upon vesting of RSUs |
| Raphi Levy Officer | Jun 26, 2026 | 20,000 | $201.00K | Jun 25, 2026 | Shares issued upon vesting of RSUs |
| Raphi Levy Officer | Jun 23, 2026 | 17,500 | $175.53K | Jun 23, 2026 | Shares issued upon vesting of RSUs |
| Raphi Levy Officer | Jun 4, 2026 | 32,500 | $290.23K | Jun 3, 2026 | Shares issued upon vesting of RSUs |
| Raphi Levy Officer | Feb 26, 2026 | 10,000 | $73.95K | Feb 25, 2026 | Restricted Stock Units |
| Amnon Gat Officer | Feb 2, 2026 | 87,010 | $603.85K | Feb 2, 2026 | Employee Stock Options plan |
| Raphi Levy Officer | Jan 14, 2026 | 15,000 | $106.35K | Jan 13, 2026 | Restricted Stock Units |
| Raphi Levy Officer | Jan 12, 2026 | 25,000 | $160.25K | Jan 9, 2026 | RSU |
| Amnon Gat Officer | Jan 9, 2026 | 61,745 | $364.30K | Jan 8, 2026 | Employee Stock Options plan |
| Raphi Levy Officer | Jan 9, 2026 | 20,000 | $118.00K | Jan 8, 2026 | RSU |
| Amnon Gat Officer | Dec 11, 2025 | 60,092 | $254.19K | Dec 10, 2025 | Employee Stock Options plan |
| Amnon Gat Officer | Dec 1, 2025 | 16,000 | $63.52K | Dec 1, 2025 | Employee Stock Options plan |